Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Am J Obstet Gynecol. 2012 Apr 28;207(1):39.e1–39.e6. doi: 10.1016/j.ajog.2012.04.022

Table 4.

Mean Total Bleeding Days Weeks 1–3

Week Type of Bleeding Overall (n=37) Normal Weight (n=18) Obese (n=19) P-Value

Week 1 Bleeding 0.8 ± 1.3 0.3 ± 0.8 1.2 ± 1.6 0.06
Spotting 1.1 ± 1.1 0.7 ±0.8 1.6 ± 1.3 0.02
Bleeding or Spotting 1.9 ± 1.8 1.0 ± 1.0 2.7 ± 2.0 0.002

Week 2 Bleeding 0.3 ± 1.0 0.1± 0.5 0.4 ± 1.3 0.4
Spotting 0.1 ± 0.4 0.1 ± 0.2 0.2 ± 0.5 0.3
Bleeding or Spotting 0.4 ± 1.3 0.2 ± 0.7 0.6 ± 1.7 0.3

Week 3 Bleeding 0.1 ± 0.3 0.1 ± 0.3 0.1 ± 0.2 0.5
Spotting 0.2 ± 0.6 0.1 ± 0.3 0.3 ± 0.7 0.5
Bleeding or Spotting 0.3 ± 0.7 0.2 ± 0.7 0.3 ± 0.8 0.7

Weeks 1–3 Overall Bleeding 1.1 ± 1.6 0.6 ± 1.0 1.6 ± 1.9 0.04
Spotting 1.5 ± 1.7 0.8 ± 1.0 2.0 ± 1.9 0.03
Bleeding or Spotting 2.6 ± 2.7 1.4 ± 1.7 3.6 ± 3.0 0.01

Mean EE2 levels during contraceptive vaginal ring use